Skip to content
Clinical Trials – home

Nicotine: Uses, Effects, and Clinical Trials

2 / 3
trials open to patients / all trials
2+
Countries

In short

This article examines the use of nicotine in various clinical trials, focusing on its applications in smoking cessation and potential benefits for other medical conditions. We'll explore different nicotine delivery methods, their effectiveness, and safety considerations based on recent studies. The research spans from traditional nicotine replacement therapies to novel applications in treating conditions like sarcoidosis and depression.

At a glance

Nicotine Delivery Methods
Transdermal patches, lozenges, inhalers, nasal sprays
Primary Applications
Smoking cessation, tobacco use disorder treatment
Secondary Applications
Pulmonary sarcoidosis treatment, depression management
Key Outcome Measures
Smoking cessation rates, nicotine blood levels, lung function, cognitive performance
Safety Considerations
Oral health effects, cardiovascular impacts, adverse events monitoring
Special Populations
Pregnant women, individuals with depression
Research Focus
Bioequivalence, pharmacokinetics, efficacy, safety

What is Nicotine?

Nicotine is a chemical compound found naturally in tobacco plants. It's the primary addictive substance in cigarettes and other tobacco products. However, nicotine is also used as a medication to help people quit smoking. When used as a medication, nicotine is often referred to as nicotine replacement therapy (NRT).

Uses of Nicotine

The main medical use of nicotine is to help people quit smoking. It works by reducing cravings and withdrawal symptoms associated with stopping tobacco use. Nicotine replacement therapy provides smokers with nicotine without the harmful chemicals found in tobacco smoke, making it easier to quit smoking gradually.

Researchers are also studying nicotine for other potential uses, including:

  • Treatment of sarcoidosis (a disease that causes inflammation in various organs)
  • Reducing betel nut chewing (a habit common in some parts of the world that can lead to oral cancer)
  • Potential effects on brain reward pathways in people with depression

Forms of Nicotine

Nicotine replacement therapy comes in several forms, including:

  • Transdermal patches: These are adhesive patches that deliver nicotine through the skin
  • Gum: Nicotine gum is chewed to release nicotine
  • Lozenges: These are tablets that dissolve in the mouth, releasing nicotine
  • Inhalers: These devices allow users to inhale nicotine vapor

Nicotine for Smoking Cessation

Nicotine replacement therapy is widely used to help people quit smoking. Clinical trials have shown that it can be effective in reducing cigarette consumption and helping smokers quit. For example, one study is comparing different approaches to using nicotine patches and other medications to help smokers quit. This study is looking at whether adjusting the treatment based on how well a person responds in the first few weeks (called an "adaptive" approach) might be more effective than a standard approach.

Nicotine Use in Pregnancy

Smoking during pregnancy can harm both the mother and the developing baby. Some researchers are studying whether nicotine replacement therapy might be a safer alternative for pregnant women who struggle to quit smoking on their own. One study is looking at the use of nicotine inhalers during pregnancy to see if they can help women quit smoking and whether they are safe for use during pregnancy. It's important to note that while nicotine replacement therapy might be safer than smoking, the safest option during pregnancy is to avoid all nicotine use if possible.

Nicotine for Other Conditions

Researchers are exploring the potential use of nicotine for conditions other than smoking cessation:

  • Sarcoidosis: A study is looking at whether nicotine patches might help treat this inflammatory condition. The researchers are measuring changes in lung function and using CT scans to see if nicotine has any effect on the disease.
  • Betel nut chewing: In some parts of the world, chewing betel nuts is a common habit that can lead to oral cancer. A study is testing whether nicotine gum might help people reduce or quit betel nut chewing.
  • Depression: One study is looking at how a single dose of nicotine might affect brain activity and mood in people with depression. This research might help us understand more about how nicotine affects the brain.

Side Effects and Safety

While nicotine replacement therapy is generally considered safer than smoking, it can still have side effects. These may include:

  • Skin irritation (from patches)
  • Mouth or throat irritation (from gum, lozenges, or inhalers)
  • Nausea
  • Headaches
  • Dizziness

Researchers carefully monitor for side effects in clinical trials. For example, one study is looking at how well nicotine patches stick to the skin and whether they cause any skin irritation. Another study is monitoring for any adverse effects when using nicotine inhalers during pregnancy.

It's important to remember that while nicotine replacement therapy can be helpful for quitting smoking, nicotine itself is still an addictive substance. These products should be used under the guidance of a healthcare provider, especially for people with certain health conditions or during pregnancy.

Questions people often ask

Conditions where Nicotine is being studied

Each condition opens its own overview and trial list

Trials with Nicotine

Recruiting trials first

See all 3 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).